Awakn Life Sciences Corp
Awakn Life Sciences Corp., a biotechnology company, engages in the research, development, operation, and delivery of psychedelic therapeutics to treat addiction and other mental health conditions in North America and Europe. It develops AWKN-001, a novel medication-assisted treatments (MAT) consisting of racemic ketamine, delivered intravenously, and manualized relapse prevention cognitive behavi… Read more
Awakn Life Sciences Corp (AWKNF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of October 2024: 0.391x
Based on the latest financial reports, Awakn Life Sciences Corp (AWKNF) has a cash flow conversion efficiency ratio of 0.391x as of October 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-594.88K) by net assets ($-1.52 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Awakn Life Sciences Corp - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Awakn Life Sciences Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Awakn Life Sciences Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Awakn Life Sciences Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Scinai Immunotherapeutics Ltd
NASDAQ:SCNI
|
-0.164x |
|
GREEN SHIFT COMMODITIES
F:7WV
|
N/A |
|
Mekong Fisheries JSC
VN:AAM
|
N/A |
|
Bounty Oil & Gas NL
PINK:BYOGF
|
-0.011x |
|
THALES - Dusseldorf Stock Exchang
DU:CSF
|
N/A |
|
Simble Solutions Ltd
AU:SIS
|
1.447x |
|
Sadot Group Inc.
NASDAQ:SDOT
|
-0.084x |
|
Tianrong Internet Products and Services Inc
PINK:TIPS
|
0.158x |
Annual Cash Flow Conversion Efficiency for Awakn Life Sciences Corp (2021–2024)
The table below shows the annual cash flow conversion efficiency of Awakn Life Sciences Corp from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-01-31 | $-1.53 Million | $-2.38 Million | 1.556x | -98.95% |
| 2023-01-31 | $-49.74K | $-7.36 Million | 148.036x | +5311.48% |
| 2022-01-31 | $3.02 Million | $-8.59 Million | -2.841x | -179.34% |
| 2021-01-31 | $465.04K | $-472.89K | -1.017x | -- |